The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting.
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2011
At a glance
- Drugs Levosimendan (Primary)
- Indications Left ventricular dysfunction
- Focus Pharmacodynamics
- 20 Sep 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 20 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2010 New trial record